TrialThe oncologist2021

Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial.

Alon Kahana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.